A Study of Amivantamab in Participants With Previously Treated Advanced or Metastatic Gastric or Esophageal Cancer

NCT04945733 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

62

Enrollment

INDUSTRY

Sponsor class

Stopped Due to reconsideration of development strategy

Conditions

Stomach Neoplasms
Esophageal Neoplasms

Interventions

DRUG: Amivantamab

Sponsor

Janssen Pharmaceutical K.K.